1. Market Research
  2. > Retail
  3. > In-Store Retail Market Trends
India Anti-Fungal Drugs Market, By Drug Class, By Indication, By Infection Type, By Route of Administration, By End-User, By Distribution Channel, By Region, Competition Forecast & Opportunities, FY2027

India Anti-Fungal Drugs Market, By Drug Class, By Indication, By Infection Type, By Route of Administration, By End-User, By Distribution Channel, By Region, Competition Forecast & Opportunities, FY2027

  • August 2021
  • 77 pages
  • ID: 6128275
  • Format: PDF
  • TechSci Research

Summary

Table of Contents

India Anti-Fungal Drugs Market, By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Dermatophytosis, Mucormycosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Parenteral, Topical, Oral, Others), By End-User (Homecare, Hospitals, Clinics, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, FY2027

India anti-fungal drugs market is expected to reach USD1562.73 million by FY2027, growing at a double digit CAGR of 10.49% over the forecast period. Increasing prevalence of fungal infections such as athlete’s foot, ringworm, candidiasis, fungal nail infection, among others is driving the demand for anti-fungal drugs in India. Anti-fungal drugs inhibit the growth of fungus on the host cell and eliminate the presence of fungal infection. Strong government support coupled with launch of various healthcare schemes such as Ayushman Bharat Pradhan Mantri Jan Arogya Yojana to provide free healthcare facilities along with reimbursement facilities to patients in dire need of receiving healthcare treatment is boosting the growth of the anti-fungal drugs market. Rising disposable income among the middle-class families is enabling them to increase their healthcare expenditure for obtaining quality treatment. Increasing investments to continue research and development activities for development of anti-fungal drugs is expected to accelerate the market growth for the forecast period. Rise in awareness towards keeping a healthy body and adoption of healthy lifestyle is fostering the anti-fungal drugs market growth. Also, the use of anti-fungal drugs in treatment of coronavirus is expected to propel the growth of the anti-fungal drugs market.

India anti-fungal drugs market is segmented into drug class, indication, infection type, route of administration, end-user, distribution channel, regional distribution, and company.Based on drug class, market is further divided into azoles, Echinocandins, polyenes, allylamines and others.

The azoles segment is expected to dominate the anti-fungal drugs market in the forecast period.Growing awareness among patients especially through social media campaigns and camps by government authorities is expected to fuel the demand for anti-fungal drugs.

Increasing sales of pharmaceuticals along with presence of disposable income is accelerating the market growth.Based on indication, the market is segmented into candidiasis, aspergillosis, dermatophytosis, mucormycosis and others.

The candidiasis segment is expected to dominate the market in the forecast period, owing to the high number of cases related to the fungal species.

The major players operating in the India anti-fungal drugs market are Pfizer India Ltd., Cipla Ltd., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories Ltd., Viatris Inc. (Mylan NV), Lupin Ltd., Zydus Cadila Ltd., Novartis India Ltd., Torrent Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Janssen Pharmaceuticals Inc. (Johnson & Johnson), Abbott Laboratories Ltd., GlaxoSmithKline Plc, Bayer AG, Dabur India Ltd., Bharat Serums & Vaccines Ltd., BDR Pharmaceuticals Internationals Pvt. Ltd., Lifecare Innovations Pvt. Ltd., Mankind Pharma and others. Major companies are developing advanced drugs and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: FY2017-FY2020
Base Year: FY2021
Estimated Year: FY2022E
Forecast Period: FY2023F–FY2027F

Objective of the Study:

• To analyze the historical growth in the market size of India anti-fungal drugs market from FY2017 to FY2021.
• To estimate and forecast the market size of India anti-fungal drugs market from FY2022 to FY2027 and growth rate until FY2027.
• To classify and forecast India anti-fungal drugs market based on drug class, indication, infection type, route of administration, end-user, distribution channel, regional distribution, and company.
• To identify dominant region or segment in the India anti-fungal drugs market.
• To identify drivers and challenges for India anti-fungal drugs market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India anti-fungal drugs market.
• To identify and analyze the profile of leading players operating in India anti-fungal drugs market.
• To identify key sustainable strategies adopted by market players in India anti-fungal drugs market.
The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of manufacturers across India.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

Through this technique, the analyst could include the manufacturers who could not be identified due to the limitations of secondary research. The analyst examined the manufacturers, distribution channels and presence of all major players across India.
The analyst calculated the market size of India anti-fungal drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these drug class and indication for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:

• Anti-fungal drugs manufacturing companies
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to anti-fungal drugs market
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India anti-fungal drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• India Anti-Fungal Drugs Market, By Drug Class:
o Azoles
o Echinocandins
o Polyenes
o Allylamines
o Others
• India Anti-Fungal Drugs Market, By Indication:
o Candidiasis
o Aspergillosis
o Dermatophytosis
o Mucormycosis
o Others
• India Anti-Fungal Drugs Market, By Infection Type:
o Superficial Fungal Infection
o Systemic Fungal Infection
• India Anti-Fungal Drugs Market, By Route of Administration:
o Parenteral
o Topical
o Oral
o Others
• India Anti-Fungal Drugs Market, By End-User:
o Homecare
o Hospitals
o Clinics
o Others
• India Anti-Fungal Drugs Market, By Distribution Channel:
o Retail Pharmacy
o Hospital Pharmacy
o Online Pharmacy

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India anti-fungal drugs market.

Available Customizations:

With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on